Drug intelligence / Profile preview

melilotus extract

Development stage
Unknown
Lead developer
Hunan Mingrui Pharmaceutical
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Melilotus extract is a botanical drug derived from the sweet clover plant (*Melilotus officinalis*), containing coumarin (1,2-benzopyrone) as its primary active constituent. It is primarily indicated for the treatment of edema and inflammation associated with soft tissue injuries, hemorrhoids, and chronic venous insufficiency. The extract works by enhancing lymphatic drainage, stimulating macrophage activity to clear protein-rich interstitial fluid, and reducing capillary permeability. In China, it is available in tablet form, with Hunan Mingrui Pharmaceutical conducting pharmacokinetic crossover studies to compare their formulation against the reference product Xie Tuo Zhi-M.

Brand names
Xie Tuo Zhi-M
Other names
Melilotus officinalis extractSweet clover extract
02

Targets

HMOX1 (Heme oxygenase 1)MMP-2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on melilotus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on melilotus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call